Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methionine--tRNA ligase, also known as methionyl-tRNA synthetase (MetRS), is an essential enzyme that catalyzes the attachment of the amino acid L-methionine to its corresponding tRNA (tRNAMet). This process, called aminoacylation or "charging" of tRNA, is a critical step in protein biosynthesis. The enzyme ensures that methionine is correctly incorporated at the start and within polypeptide chains during translation. MetRS plays a dual role in translation: charging initiator tRNAs for initiation and elongator tRNAs for methionine incorporation during elongation. During cellular stress, post-translational modifications can alter substrate specificity, potentially serving protective roles.
Inhibition of methionyl-tRNA synthetase, preventing tRNA charging with methionine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methionine--tRNA ligase (None).